Efficacy of pharmacological treatments of neuropathic pain: An update and effect related to mechanism of drug action

Pain

Volumn 83, Issue 3, 1999, Pages 389-400

  Sindrup, Søren H ^a   Jensen, Troels S ^b  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Neuropathic pain; Pharmacological treatments; Placebo controlled trials

Indexed keywords

CAPSAICIN; CARBAMAZEPINE; DEXTROMETHORPHAN; GABAPENTIN; IMIPRAMINE; MEXILETINE; OXYCODONE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ANALGESIC ACTIVITY; CLINICAL TRIAL; DRUG EFFICACY; DRUG MECHANISM; DRUG TOLERABILITY; HUMAN; NEUROPATHY; PAIN; PRIORITY JOURNAL; REVIEW;

ANALGESICS; ANIMALS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; CARBAMAZEPINE; DIABETIC NEUROPATHIES; HUMANS; N-METHYLASPARTATE; NARCOTICS; NEURALGIA; PAIN; POLYNEUROPATHIES; RANDOMIZED CONTROLLED TRIALS; SEROTONIN UPTAKE INHIBITORS;

EID: 0032729936     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3959(99)00154-2     Document Type: Review

References (83)

1. Arner S., Meyerson B.A. Lack of effect of opioids on neuropathic and idiopathic forms of pain. Pain. 33:1988;11-23.
2. Backonja M., Beydoun A., Edwards K.R., Schwartz S.L., Fonseca V., Hes M., LaMoreaux L., Garofalo E. for the Gabapentin Diabetic Neuropathy Study Group. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus. A randomised controlled trial. J Am Med Assoc. 280:1998;1831-1836.
3. Bennett G.J. Neuropathic pain. Wall P.D., Melzack P.D., Melzack R. Textbook of Pain. 3rd ed :1994;494-510 Churchill Livingstone, Edinburgh.
4. Bernstein J.E., Korman N.J., Bickers D.R., Dahl M.V., Millikan L.E. Topical capsaicin treatment of chronic postherpetic neuralgia. J Am Acad Dermatol. 21:1989;265-270.
5. Bowsher D. The effects of pre-emptive treatment of postherpetic neuralgia with amitriptyline: a randomized, double-blind, placebo-controlled trial. J Pain Symptom Manage. 13:1997;327-331.
6. Broadley K.E., Kurowska A., Tookman A. Ketamine injection used orally. Palliat Med. 10:1996;247-250.
7. Campbell F.G., Graham J.G., Zilkha K.J. Clinical trial of carbamazepine (Tegretol) in trigeminal neuralgia. J Neurol Neurosurg Psychiatry. 29:1966;265-267.
8. Canavero S., Bonicalzi V. Lamotrigine control of central pain. Pain. 68:1996;179-181.
9. Capsaicin Study Group. Treatment of painful diabetic neuropathy with topical capsaicin. A multicenter, double-blind, vehichle-controlled study. Arch Intern Med. 151:1991;2225-2229.
10. Chad D.A., Aronin N., Lundstrom R., McKeon P., Ross D., Molitch M., Schipper H.M., Stall G., Dyess E., Tarsy D. Does capsaicin relieve the pain of diabetic neuropathy. Pain. 42:1990;387-388.
11. Chadda V.S., Mathur M.S. Double blind study of the effects of dipenylhydantoin sodium on diabetic neuropathy. J Assoc Phys Ind. 26:1978;403-406.
12. Chiou-Tan F.Y., Tuel S.M., Johnson J.C., Priebe M.M., Hirsh D.D., Strayer J.R. Effect of mexiletine on spinal cord injury dysesthetic pain. Am J Phys Med Rehab. 75:1996;84-87.
13. Cook R.J., Sackett D.L. The number needed to treat: a clinically useful measure of treatment effect. Br. Med. J. 310:1995;452-454.
14. Dejgard A., Petersen P., Kastrup J. Mexiletine for treatment of chronic painful diabetic neuropathy. Lancet. 2:1988;9-11.
15. Dellemijn P.L.I., Vanneste J.A.L. Randomised double-blind active-controlled crossover trial of intravenous fentanyl in neuropathic pain. Lancet. 349:1997;753-758.
16. Devor M., Wall P.D., Catalan N. Systemic lidocaine silences ectopic neuroma and DRG discharge without blocking nerve conduction. Pain. 48:1992;261-268.
17. Dray A. Agonists and antagonists of nociception. Jensen T.S., Turner J.A., Wiesenfeld-Hallin Z. Proceedings of the 9th World Congress on Pain. 1997;279-292 IASP press, Seattle.
18. Dray A., Urban L., Dickenson A. Pharmacology of chronic pain. Trends Pharmacol Sci. 15:1994;190-197.
19. Eide P.K., Jørum E., Stubhaug A., Bremnes J., Breivik H. Relief of postherpetic neuralgia with the NMDA receptor antagonist ketamine: a double-blind cross-over comparison with morphine and placebo. Pain. 58:1994;347-354.
20. Eisenberg E., Alon N., Ishay A., Daoud D., Yarnitsky D. Lamotrigine in the treatment of painful diabetic neuropathy. Eur J Neurol. 5:1998;167-173.
21. Eisenberg E., Kleiser A., Dortort A., Haim T., Yarnitsky D. The NMDA (N-methyl-D-aspartate) receptor antagonist memantine in the treatment of postherpetic neuralgia: a double-blind, placebo-controlled study. Eur J Pain. 2:1998;321-327.
22. Ertas M., Sagduyu A., Arac N., Uludag B., Ertekin C. Use of levodopa to relieve pain from painful symmetrical diabetic polyneuropathy. Pain. 75:1998;257-259.
23. Felsby S., Nielsen J., Arendt-Nielsen L., Jensen T.S. NMDA receptor blockade in chronic neuropathic pain: a comparison of ketamine and magnesium chloride. Pain. 64:1996;283-291.
24. Fields H.L. Pain syndromes in neurology. 1990;Butterworths, London.
25. Fromm G.H., Terrence C.F. Comparison of L-baclofen and racemic baclofen in trigeminal neuralgia. Neurology. 37:1987;1725-1728.
26. Fromm G.H., Terrence C.F., Chattha A.S. Baclofen in the treatment of trigeminal neuralgia: double-blind study and long term follow up. Ann Neurol. 15:1984;240-244.
27. Gomez-Perez F.J., Rull J.A., Dies H., Rodriguez-Rivera G., Gonzlez-Barranco J., Lozano-Castaeda O. Nortriptyline and fluphenazine in the symptomatic treatment of diabetic neuropathy. A double-blind cross-over study. Pain. 23:1985;395-400.
28. Hall H., Ögren S.O. Effects of antidepressant drugs on different receptors in brain. Eur. J. Pharmacol. 70:1981;393-407.
29. Harati Y., Gooch C., Swenson M., Edelman S., Greene D., Raskin P., Donofrio P., Cornblath D., Sachdeo R., Siu C.O., Kamin M. Double-blind randomized trial of tramadol for the treatment of pain of diabetic neuropathy. Neurology. 50:1998;1842-1846.
30. Jensen T.S. Mechanism of neuropathic pain. Campbell J.N. Pain, 1996, an updated review. 1996;77-86 IASP Press, Seattle.
31. Jensen T.S., Yaksh T.L. Effects of an intrathecal dopamine agonist, apomorphine, on thermal and chemical evoked noxious responses in rats. Brain Res. 296:1984;285-293.
32. Kalso E., Tasmuth T., Neuvonen P.J. Amitriptyline effectively relieves neuropathic pain following treatment of breast cancer. Pain. 64:1995;293-302.
33. Kastrup J., Petersen P., Dejgård A., Angelo H., Hilsted J. Intravenous lidocaine infusion-a new treatment of chronic painful diabetic neuropathy? Pain. 28:1987;69-75.
34. Kembaum S., Hauchecome J. Administration of levodopa for relief of herpes zoster pain. J Am Med Assoc. 246:1981;132-134.
35. Killian J.M., Fromm G.H. Carbamazepine in the treatment of neuralgia. Use and side effects. Arch Neurology. 19:1968;129-136.
36. Kvinesdal B., Molin J., Frøland A., Gram L.F. Imipramine treatment of painful diabetic neuropathy. J Am Med Assoc. 251:1984;1727-1730.
37. 2+ exchange in rat brain synaptosomes. Can J Physiol Pharmacol. 68:1990;1414-1418.
38. Leijon G., Boivie J. Central post-stroke pain-a controlled trial of amitriptyline and carbamazepine. Pain. 36:1989;27-36.
39. Low P.A., Opfer-Gehrking T.L., Dyck P.J., Litchy W.J., O'Brien P.C. Double-blind, placebo-controlled study of the application of capsaicin cream in chronic distal painful polyneuropathy. Pain. 62:1995;163-168.
40. Max M.B., Culnane M., Schafer S.C., Gracely R.H., Walther D.J., Smoller B., Dubner R. Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood. Neurology. 37:1987;589-596.
41. Max M.B., Kishore-Kumar R., Schafer S.C., Meister B., Gracely R., Smoller B., Dubner R. Efficacy of desipramine in painful diabetic neuropathy: a placebo-controlled trial. Pain. 45:1991;3-9.
42. Max M.B., Lynch S.A., Muir J., Shoaf S.E., Smoller B., Dubner R. Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. N Eng J Med. 326:1992;1250-1256.
43. Max M.B., Byas-Smith M.G., Gracely R.H., Bennett G.J. Intravenous infusion of the NMDA antagonist, ketamine, in chronic post-traumatic pain and allodynia: a double-blind comparison to alfentanil and placebo. Clin Neuropharmacol. 18:1995;360-368.
44. McQuay H.J., Moore R.A. An evidence based resource for pain relief. 1998;Oxford University Press, Oxford.
45. McQuay H.J., Carroll D., Glynn C.J. Dose-response for analgesic effect of amitriptyline in chronic pain. Anaesthesia. 48:1993;281-285.
46. McQuay H.J., Jadad A.R., Carroll D., Faura C., Glynn C.J., Moore R.A., Liu Y. Opioid sensitivity of chronic pain: a patient-controlled analgesia method. Anaesthesia. 47:1992;757-767.
47. McQuay H.J., Carroll D., Jadad A.R., Glynn C.J., Jack T., Moore R.A., Wiffen P.J. Dextromethorphan for the treatment of neuropathic pain: a double-blind randomised controlled crossover trial with integral n-of-1 design. Pain. 59:1994;127-133.
48. McQuay H., Carroll D., Jadad A.R., Wiffen P., Moore A. Anticonvulsant drugs for management of pain: a systematic review. Br. Med. J. 311:1995;1047-1052.
49. McQuay H.J., Tramer M., Nye B.A., Carroll D., Wiffen P., Moore A. A systematic review of antidepressants in neuropathic pain. Pain. 68:1996;217-227.
50. Moore R.A., Gavaghan D., Tramer M.R., Collins S.L., McQuay H.J. Size is everything - large amounts of information are needed to overcome random effects in estimating direction and magnitude of treatment effects. Pain. 78:1998;209-216.
51. Nelson K.A., Park K.M., Robinovitz E., Constantine T., Max M.B. High-dose oral dextromethorphan versus placebo in painful diabetic neuropathy and potherpetic neuralgia. Neurology. 48:1997;1212-1218.
52. Nicol C.F. A four year double blind study of tegretol in facial pain. Headache. 9:1969;54-57.
53. Nikolajsen L., Hansen P.O., Jensen T.S. Oral ketamine therapy in the treatment of post-amputation stump pain. Acta Anaesthesiol Scand. 41:1997;329-331.
54. Oskarsson P., Lins P.E., Ljunggren J.G. Efficacy and safety of mexiletine in the treatment of painful diabetic neuropathy. Diabetes Care. 20:1997;1594-1597.
55. + channels by antidepressant drugs. J Pharmacol Exp Ther. 284:1998;208-214.
56. Portenoy R.K., Foley K.M., Inturrisi C.E. The nature of opioid responsiveness and its implications for neuropathic pain: new hypotheses derived from studies of opioid infusions. Pain. 43:1990;273-286.
57. Reynolds I.J., Miller R.J. Tricyclic antidepressants block N-methyl-D-aspartate receptors: similarities to the action of zinc. Br J Pharmacol. 95:1988;95-102.
58. Rosenberg J.M., Harrell C., Ristic H., Werner R.A., de Rosayro A.M. The effect of gabapentin in neuropathic pain. Clin J Pain. 13:1997;251-255.
59. Rowbotham M., Harden N., Stacey B., Bernstein P., Magnus-Miller L. for the Gabapentin study group. Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial. J Am Med Assoc. 280:1998;1837-1842.
60. Rowbotham M.C., Reisner-Keller L.A., Fields H.L. Both intravenous lidocaine and morphine reduce pain of postherpetic neuralgia. Neurology. 41:1991;1024-1028.
61. ®): double blind crossover trial. Diabetologia. 5:1969;215-218.
62. Saudek C.D., Werns S., Reidenberg M. Phenytoin in the treatment of diabetic symmetrical polyneuropathy. Clin Pharmacol Ther. 22:1977;196-199.
63. Scheffler N.M., Sheitel P.L., Lipton M.N. Treatment of painful diabetic neuropathy with capsaicin. J Am Pediatr Med Assoc. 31:1991;288-293.
64. Sindrup S.H. Antidepressants in the treatment of diabetic neuropathy symptoms. Pharmacodynamic, -kinetic, and -genetic aspects. Dan Med Bull. 41:1994;66-78.
65. Sindrup S.H., Gram L.F., Brøsen K., Eshøj O., Mogensen E.F. The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms. Pain. 42:1990;135-144.
66. Sindrup S.H., Gram L.F., Skjold T., Grodum E., Brøsen K., Beck-Nielsen H. Clomipramine vs. desipramine vs. placebo in the treatment of diabetic neuropathy symptoms. A double-blind cross-over study. Br J Clin Pharmacol. 30:1990;683-691.
67. Sindrup S.H., Gram L.F., Skjold T., Frøland A., Beck-Nielsen H. Concentration-response relationship in imipramine treatment of diabetic neuropathy symptoms. Clin Pharmacol Ther. 47:1990;509-515.
68. Sindrup S.H., Tuxen C., Gram L.F., Grodum F., Skjold T., Brøsen K., Beck-Nielsen H. Lack of effect of mianserin on the symptoms of diabetic neuropathy. Eur J Clin Pharmacol. 43:1992;251-255.
69. Sindrup S.H., Bjerre U., Dejgaard A., Brssen K., Aaes-Jørgensen T., Gram L.F. The selective serotonin reuptake inhibitor citalopram relieves the symptoms of diabetic neuropathy. Clin Pharmacol Ther. 52:1992;547-552.
70. Sindrup S.H., Andersen G., Madsen C., Brøsen K., Smith T., Jensen T.S. Tramadol relieve pain and allodynia in polyneuropathy. A randomised, double-blind, placebo-controlled trial. Pain. 83:1999;85-90.
71. Stracke H., Meyer U.F., Schumacher H.F., Federlin K. Mexiletine in the treatment of diabetic neuropathy. Diabetes Care. 15:1992;1550-1555.
72. Tandan R., Lewis G.A., Krusinski P.B., Badger G.B., Fries T.J. Topical capsaicin in painful diabetic neuropathy - controlled study with long-term follow-up. Diabetes Care. 15:1992;8-14.
73. Tasmuth, Kalso. 21st Annual meeting of the Scandinavian Association for the study of Pain. 1998.
74. 1-receptors: fact and artifact. Eur J Pharmacol. 67:1980;41-46.
75. Vestergaard K., Andersen G., Jensen T.S. Treatment of central post-stroke pain with a selective serotonin reuptake inhibitor. Eur J Neurol. 3(suppl. 5):1996;169.
76. Vrethem M., Boivie J., Arnqvist H., Holmgren H., Lindstrom T., Thorell L.H. A comparison of amitriptyline and maprotiline in the treatment of painful polyneuropathy in diabetics and non-diabetics. Clin J Pain. 13:1997;313-323.
77. Watson C.P.N., Babul N. Efficacy of oxycodone in neuropathic pain: a randomized trial in postherpetic neuralgia. Neurology. 50:1998;1837-1841.
78. Watson C.P.N., Evans R.J. The post-mastectomy pain syndrome and topical capsaicin: a randomised trial. Pain. 51:1992;375-379.
79. Woolf C.J., et al. Towards a mechanism-based classification of pain. Pain. 77:1998;227-229.
80. Wright J.M., Oki J.C., Graves L. Mexiletine in the symptomatic treatment of diabetic peripheral neuropathy. Ann Pharmacother. 31:1997;29-34.
81. Yaksh T.L. Preclinical models of nociception. Yaksh T.L., Lynch C., Zapol W.M., Biebuyck J.F., Saidman L.J. Anesthesia: biological foundations. 1997;685-718 Lippencott-Raven Publishers, Philadelphia.
82. Zakrzewska J.M., Patsalos P.N. Oxcarbazepine: a new drug in the management of intractable trigeminal neuralgia. J Neurol Neurosurg Psychiatry. 52:1989;472-476.
83. Zakrzewska J.M., Chaudhry Z., Nurmikko T.J., Patton D.W., Mullens E.L. Lamotrigine (Lamictal) in refractory trigeminal neuralgia: results from a double-blind placebo controlled trial. Pain. 73:1997;223-230.